Oncologist Email List: Subspecialty Segmentation That Lifts Response

Consider an illustrative marketing manager at a company that sells a companion diagnostic. She buys an oncologist email list of 5,000 contacts and sends everyone the same message about a new biomarker test. A radiation oncologist deletes it, a pediatric hematologist-oncologist wonders why it mentions a cancer she never treats and a lung cancer specialist, the intended reader, finds it too generic to answer. Replies trickle in at a rate that disappoints the team. The list was fine, but the message ignored who was reading.

This article explains how to segment an oncologist email list by discipline, disease site, practice setting and role, and what that segmentation can and can’t do for response. It draws on a 2020 JCO Oncology Practice study of the US oncology workforce, the NUCC provider taxonomy as shown on a public lookup site, an IQVIA blog, an H1 blog and a OneOncology post. Vendor figures are mostly unsourced, so each is attributed. Confirm legal points with counsel.

TL;DR

• Oncologists aren’t a single audience. The Shih, Kim and Halpern workforce study counted 28,681 US oncologists in 2019 and split them into medical and hematology-oncology, radiation and pediatric groups, among others. A message that suits a single group can miss another entirely, so segment by discipline first and by disease site second. Start with the discipline split.
• Segments rely on imperfect data. The study notes that taxonomy codes are self-selected, that NPIs list a single location and that deactivation isn’t automatic. IQVIA claims up to 40% of healthcare professionals change segments within 6 months. Verify records and refresh them before each campaign, then judge segments by replies rather than opens.
• The lift is a hypothesis to test. In the invented example here, a segmented send that lifts response from 1.0% to 1.6% on 5,000 contacts adds 30 replies. No source I found measures the lift for oncologist lists, so run your own split tests.

What segmentation means for an oncology list

Segmentation splits a list into audiences that need different messages. In practice you group contacts by shared attributes, such as discipline, the cancers they treat, where they practice and what role they play in decisions. H1, a healthcare data vendor, lists segmenting by specialty, training, skills, known interests and geography as its first tip for emailing physicians. The reasoning is simple: relevance earns attention, and generic mass marketing earns deletion, especially from clinicians with staff who screen their inboxes.

Oncology rewards finer segmentation than most fields. The field spans physicians who prescribe drugs, those who deliver radiation, those who operate and those who treat children, and within each group many clinicians focus on particular tumor types. OneOncology, a practice network, organizes its physicians into disease groups for gastrointestinal, genitourinary, breast, lung and hematologic cancers. That network publishes the post to promote itself, but the structure illustrates how oncologists often organize their work.

A segment is only useful if you can act on it. There’s no point tagging 12 disease sites if you can’t write 12 relevant messages, or if your data can’t place contacts reliably. Start with the splits you can support with data and content, test whether they change response, and add detail where results justify it. The sections below move from the broad discipline split to disease sites, then to data quality, messaging, compliance and measurement.

Expect a modest, testable gain rather than a guarantee. I haven’t found a published study that measures how much subspecialty segmentation lifts response among oncologists. IQVIA reports that triggered emails achieved a 33% open rate versus 25.3% for broadcast emails, but its post names no sample and promotes its own services. Treat any promised lift with suspicion, including the invented figure in this article, and plan a controlled test before you commit a budget.

Who counts as an oncologist

The first question is who belongs on the list. In the US, the National Provider Identifier system gives every clinician a code, and each record carries a taxonomy code that describes the type of care. The NUCC code set, shown on the lookup site 2minutemedicine, includes 207RX0202X for medical oncology and 207RH0003X for internal medicine, hematology and oncology. That site notes that a code describes the type of care, not a license or board certification, so a code is a self-described label rather than proof of training.

Other disciplines have their own codes, and the study by Shih and colleagues used taxonomy codes to find oncologists in the NPPES downloadable file, downloaded on October 1, 2019. The authors identified 28,681 oncologists, 1,090 oncology pharmacists and several hundred other nonphysician workers. They note that no oncology taxonomy exists for nurse practitioners or physician assistants, so nonphysician oncology staff are likely undercounted. If your product is relevant to those clinicians, a taxonomy filter will miss many of them.

Decide your target definition before you buy or build a list. A company selling radiation planning software cares about radiation oncologists and physicists. A company selling lung cancer therapy cares about medical oncologists who treat lung cancer, plus thoracic surgeons and pulmonologists who refer. Write the definition down, including the roles you’ll exclude, and give it to your list vendor. A clear definition lets you check whether the contacts you receive match what you asked for.

Oncology physician types and rough workforce shares

The table uses the Shih, Kim and Halpern study of the 2019 workforce, published in JCO Oncology Practice in December 2020. The counts are my arithmetic from the percentages the paper reports, so they’re approximate. The paper gives “more than 55%” for the combined medical oncology and hematology-oncology group, which makes the first row a minimum. The text I could read didn’t report surgical or gynecologic oncology shares, so the final row shows only what’s left over.

Group	Share reported	Approximate count	Caveat
Medical oncology and hematology-oncology	More than 55% combined	At least 15,775	Count is my arithmetic; “more than” makes it a minimum
Radiation oncology	20.6%	About 5,908	From the paper’s text
Pediatric hematology-oncology	10.5%	About 3,012	From the paper’s text
Remainder, including surgical and gynecologic oncology	Up to about 13.9%	Up to about 3,987	Not reported separately in the text I read

Keep the caveats in mind when you use these numbers. The snapshot dates from 2019, it relies on self-selected taxonomy codes and each NPI lists only a single practice location, even though clinicians may work at several sites. The authors also note that NPI deactivation isn’t automatic, so some listed providers may be retired. Use the table to gauge relative group sizes rather than to count your addressable market, and ask your list vendor for counts by discipline so you can compare.

Segmenting by discipline

• Medical and hematology-oncology. This is the largest group in the study, and it includes clinicians who prescribe drugs and manage patients over long periods. Messages about therapies, biomarkers, supportive care and clinical trials usually belong here. Split further by disease site where your data allows, because a hematologist who treats lymphoma and a medical oncologist who treats breast cancer read a therapy announcement through very different lenses. Ask your vendor to tag this group carefully.
• Radiation oncology. The study counts about 1 in 5 oncologists in this group, at 20.6%. Radiation oncologists care about treatment planning, delivery equipment, imaging, physics support and protocols, so a drug message may be irrelevant to them unless it touches combined treatment. Segment them away from medical oncology for anything about systemic therapy, and send them content about technology, workflow and safety instead. Check that your vendor can separate physicians from physicists and dosimetrists.
• Surgical and gynecologic oncology. The study text I read doesn’t report their shares, so ask your vendor for counts. Surgical oncologists respond to content about operative technique, margins, perioperative care and equipment. Gynecologic oncologists treat cancers of the female reproductive system and often combine surgery with chemotherapy decisions. Because they sit between surgery and medical care, they may need messages that differ from either neighboring group. Ask which tags your vendor uses for them.
• Pediatric hematology-oncology. The study counts 10.5% in this group. Childhood cancers differ from adult cancers in biology, treatment and trial structure, and the audience is far smaller for most adult products. Sending an adult therapy message to a pediatric specialist wastes a send and can harm your sender reputation. Include this group only when your product has a pediatric indication or a relevant resource, and write specifically for it. Verify the indication first.

Segmenting by disease site

Disease site is the most useful second split. Within medical oncology, many clinicians focus on a tumor type, and networks such as OneOncology organize physicians into groups for gastrointestinal, genitourinary, breast, lung and hematologic malignancies. Those 5 groups are an example rather than a universal taxonomy, since other practices use different structures and many community oncologists treat several cancers. Pick the disease sites that matter to your product, and define each in terms your data can express.

Disease-site data is harder to get than discipline data. Taxonomy codes in the NPI file show broad specialty, not tumor focus. You may find disease focus in practice websites, clinical trial listings, publications, conference activity or vendor-supplied tags. Each source has gaps and delays, and an oncologist’s focus can shift over time. Ask your list provider how it assigns disease-site tags, how often it refreshes them and what share of the list carries a tag at all.

Treat inferred tags as probabilities. A contact tagged “lung” because a practice website lists thoracic oncology might see patients with several cancers. Use inferred tags to prioritize, not to exclude. For a lung-specific message, send first to contacts with strong evidence, such as publications or trial roles. Then test a second wave to those with weaker evidence and compare response. The comparison shows how much accuracy your tags have, which guides how strictly you can filter.

Avoid over-slicing small segments. A narrow disease segment may contain only a few hundred contacts, and splitting it further leaves too few to test. Small samples produce noisy response rates that swing wildly between campaigns. Keep segments large enough to learn from, combine neighbors when needed and accept a broader message for the rest. Document each segment’s size and rule so that later campaigns use the same definitions and results stay comparable.

Fields that drive segmentation

The table lists the fields a segmented oncologist list needs, why each matters and where the data usually comes from. It’s my own checklist rather than a standard. Ask your vendor to show a sample record with these fields and to say how each was derived. A field with no stated source is a guess, and a field with no verification date can’t be trusted for targeting. Keep the checklist with your vendor contract.

Field	Why it matters	Typical source	Accuracy risk
Discipline	Separates drug, radiation, surgical and pediatric audiences	NPI taxonomy, society directories	Self-selected codes
Disease site	Lets you match message to tumor type	Practice sites, trials, publications	Inferred and often stale
Practice setting	Community, academic or hospital-based context	Practice and hospital data	Affiliations change
Network or group affiliation	Shows who shares pathways and purchasing	Practice network sites	Mergers and rebranding
Role	Prescriber, administrator, researcher or director	Titles and bios	Titles vary widely
State and region	Supports local events and rules	NPI address	A single location per NPI
Last verified date	Shows how old the record is	Vendor process	Often missing
Email type	Work, shared or personal	Vendor tagging	Mislabeled addresses

Practice setting and role

Setting changes what a message should say. A physician in an academic center cares about research, trials and teaching, whereas a community oncologist often runs a busy clinic and cares about workflow, reimbursement and patient access. Practice networks add another layer: OneOncology’s post shows that disease groups in a network shape education and trial priorities, and affiliated practices may share pathways. If your product touches those pathways, the network contact matters as much as the individual physician.

Role matters as well. A medical oncologist may prescribe, a practice administrator may handle purchasing and a nurse navigator or pharmacist may influence adoption. The study notes that oncology pharmacists tend to cluster in counties that already have oncologists, and that no taxonomy exists for oncology nurse practitioners or physician assistants. If you need those roles, ask your vendor how they identify them. Segment by role so that clinical messages go to clinicians and operational messages go to people who run the practice.

Geography affects reach too. The study found that 64% of US counties had no oncologists practicing in them, and the mean density was 2.94 oncologists per 100,000 people. Your list will therefore cluster in counties with cancer centers and larger practices, and rural oncologists will be rare and valuable. If your product serves community or rural practices, check that your list includes them, since a list drawn only from large centers will skew your results toward academic settings.

Data sources and their limits

• NPI registry data. The NPPES file is public and underlies the Shih study, but the authors list its limits: a single practice location per NPI, no automatic deactivation and self-selected taxonomy. Email addresses aren’t part of it, so a vendor must add them. Treat NPI data as a way to build a roster, then verify each record before you rely on it for targeting or addressing. Plan for that cleanup work before launch.
• Specialty society and conference lists. Professional societies and meetings hold member and attendee data that can be accurate, but their use is often restricted by membership terms and privacy rules. Don’t scrape or reuse a list without permission. If a vendor claims to hold such data, ask how it was obtained and whether the terms allow commercial email. I haven’t verified any society’s rules here, so confirm with the organization.
• Licensed physician files. Some organizations sell physician databases, and a few are maintained by professional bodies. I haven’t verified the terms, accuracy or licensing conditions of any of them for this article. Ask each seller for a written description of the sources, the update cycle and the permitted uses, and keep that description with the contract. Compare at least 2 sellers on the same sample of your own known contacts.
• Vendor-built databases. Many vendors assemble contacts from several sources, and claims about accuracy rarely come with published methods. IQVIA and H1 both sell data or services in this space, so their blog figures serve their business. A simple test helps: give the vendor 50 oncologists you know, ask for their records and check how many are correct, current and properly tagged. Run that test before you sign, and repeat it every year afterward.

Data quality in a moving field

Records age quickly. IQVIA’s blog claims that up to 40% of healthcare professionals change segments within 6 months, and that they frequently move between personal and institutional email accounts. The post names no sample and promotes IQVIA’s services, so treat the 40% as a vendor claim. Still, the direction fits common sense: clinicians change jobs, merge practices, shift focus and update addresses. An oncologist tagged to lung cancer last year may now lead a clinical trial program or manage a department.

The Shih study adds structural reasons for caution. NPI records list a single practice location although clinicians may work at several sites. Deactivation isn’t automatic, so some listed providers may no longer practice. Taxonomy codes are self-selected, so misclassification is possible, and the authors said their counts of nonphysician workers didn’t fully match between sections. These issues affect any list built on NPI data, and they mean you should expect some wrong addresses, retired clinicians and mislabeled specialties.

Build a refresh routine. Before each campaign, verify addresses, remove bounces and update tags from reply data. When someone responds, record what you learn, such as their disease focus or role. When someone opts out, suppress them everywhere. Keep a last-verified date on every record, and avoid mailing contacts whose dates are old without checking first. A smaller, fresher list usually performs better than a large, stale list, and it protects your sender reputation with the health systems that filter your messages.

Message by segment

The table sketches how a message might change by segment. The content column is my judgment rather than sourced guidance, so test it with your own audience. Every healthcare marketing message also has to follow your regulatory and compliance rules, which depend on the product and the claims you make. Ask your regulatory and legal reviewers to approve each segment’s version before sending, since a message to a surgeon and a message to a drug prescriber raise different issues.

Segment	What to lead with (my judgment)	Avoid
Medical and hematology-oncology	Clinical relevance to their tumor types; evidence summary	Claims outside the approved scope
Radiation oncology	Workflow, planning, safety, equipment support	Drug-focused messages
Surgical and gynecologic	Technique, perioperative care, devices	Generic therapy announcements
Pediatric hematology-oncology	Pediatric data or resources, if available	Adult-only content
Practice administrators	Operations, access, workflow	Clinical detail they can’t act on
Pharmacists and nurses	Handling, education, patient support	Prescribing language

Compliance basics for physician email

Business email isn’t exempt. Sender, an email platform, summarizes the FTC’s CAN-SPAM guide and says there’s no business-to-business exception. Its list of requirements includes accurate headers, non-deceptive subject lines, clear identification of an advertisement, a valid physical address, a working opt-out honored within 10 business days and oversight of anyone who sends for you. I couldn’t open the FTC guide itself, so confirm these points with counsel. Counsel can confirm the details.

Promotional content may face extra rules. If your message promotes a drug, device or test, regulators may restrict what you can claim and how you present risk, and companies often run messages through medical, legal and regulatory review. I haven’t researched those rules for this article. Ask your reviewers which claims, references and disclosures each segment’s message needs, and keep a record of approvals. A message that works for a single segment may be inappropriate for another.

Privacy and sending rules vary by place. State privacy laws and rules for contacts outside the US may add requirements, and I haven’t researched them here. A physician’s work email isn’t patient information, though combining lists with other data can raise issues. Ask counsel before you merge datasets, buy a list from an unfamiliar vendor or send to contacts in other countries, and record where each address came from. Keep that record safe.

Your vendor’s mistakes are yours. Sender’s summary says liability can’t be transferred to vendors, using the phrasing “their violations are your violations.” If a list seller or agency sends for you and breaks a rule, you may still be responsible. Put compliance duties, audit rights and a stop-campaign right into contracts, and ask counsel to review the wording. Keep suppression lists current across every tool and sender. Review those clauses before you sign.

Testing and measuring lift

• Test a single variable at a time. H1’s guide recommends split testing a single element, such as the subject line, the topic or the call to action. For segmentation tests, the variable is the message version: send a group the generic message and another group a segment-specific version, with groups randomly drawn from the same segment. If you change the audience and the content at once, you can’t tell which caused the difference.
• Judge by replies and actions. Open rates can mislead because mail privacy features and automatic scanning can inflate them, though I haven’t sourced a rate. Track replies, link clicks, meeting requests and downloads, and tie them to the segment. IQVIA reports 84% of emails read on mobile, a figure with an unclear base, so check that your landing pages work on a phone before you measure clicks. Ask for exports of raw reply data.
• Size your samples honestly. A segment of 300 contacts with a 1% response rate yields 3 replies, which is too few to compare. Combine campaigns over time, or test on larger segments first. Record the dates, versions and counts, and avoid declaring a winner from a handful of replies. If a result looks dramatic, repeat the test before you change your whole program. Repeat the test on a fresh sample before you act.
• Report the gain with its limits. When you share results with leadership, state the sample sizes, the date range and the assumptions. Note any change in list quality between campaigns, since a cleaner list can lift response regardless of segmentation. Compare against a control group where you can. Honest reporting builds trust, and it protects you when a later campaign performs worse than the first. Keep the original data in case questions arise.

An illustrative segmentation test

An invented company sends 5,000 oncologists. Its generic message earns a 1.0% response, or 50 replies. After segmenting by discipline and disease site and rewriting messages, suppose response rises to 1.6%, or 80 replies, a 60% relative lift. The lift is assumed, not sourced. Segmentation takes 40 hours of work at an invented $120 an hour, or $4,800. Dividing that cost by the 30 extra replies gives $160 per added reply.

Item (invented)	Calculation	Result
Generic replies at 1.0%	5,000 × 0.010	50
Segmented replies at 1.6%	5,000 × 0.016	80
Added replies	80 minus 50	30
Relative lift	1.6 ÷ 1.0 minus 1	60%
Segmentation cost	40 hours × $120	$4,800
Cost per added reply	$4,800 ÷ 30	$160

The example ignores the costs of the list, the email platform and review time, and it assumes the test result would hold in later campaigns. Segments also decay: if IQVIA’s 40% 6-month figure were right, 2,000 of the 5,000 contacts would have moved segments within half a year. That would erode the gain unless you refresh. Replace each invented input with your own measurements, and compare the cost per added reply with the value of a reply to your business.

Cadence and staff screening

H1’s guide warns that physicians often have staff filter their email, and it recommends messages written as if from a colleague, subject lines without a sales tone and sparing use of time-sensitive requests. The post dates from 2018 and cites sources from around 2016, so its advice is dated, though it matches common practice. In oncology, where clinics are busy and gatekeepers are common, a message that reads like a colleague’s note has a better chance of passing the screen than a promotional blast.

For frequency, the same guide suggests about 2 emails a month, 2 weeks apart, for long-term campaigns and weekly emails for campaigns of 30 days or less. It offers no primary data for those numbers, so treat them as a starting point. Watch your own unsubscribe and complaint rates by segment, and slow down where they rise. A radiation oncologist who receives a weekly drug message will opt out quickly, whereas the same cadence of relevant content may be welcome.

Keep each message short, with a clear subject line and a single ask. H1 describes the subject line as the main gatekeeper and recommends relevance, newness and brevity, and it advises linking to longer content on your website. Offer something useful, such as a data summary or a webinar invitation, and make the opt-out easy to find. When a recipient replies with a question, answer promptly with a named person, since a fast, helpful response often matters more than the first message.

Mistakes teams make with oncologist lists

• Treating oncologists as a single audience. The workforce study splits oncologists into medical, radiation, pediatric and other groups, and a single message can’t serve them all. Start with the discipline split, add disease site where data allows and write at least 1 message per major segment. Measure response by segment from the first campaign, so you learn which splits matter and which add effort without benefit. Review the segment list with sales too.
• Trusting tags without checking. Disease-site and role tags are often inferred, and the study’s limits on taxonomy codes show how easily labels drift. Test a sample of 50 contacts you know, compare the tags with reality and adjust how strictly you filter. Use weak tags to prioritize rather than exclude. Ask the vendor to explain how each tag is built and refreshed, and get the answer in writing. Document the sample results.
• Over-slicing small segments. A segment of 150 contacts can’t support a reliable test. Teams that slice too finely write many messages and learn nothing from the results. Merge neighboring segments until each has enough contacts to test, and keep a written definition of each segment. Revisit the definitions each quarter, since clinicians’ focus and affiliations change and your counts will drift. Pool results across several campaigns when a segment stays small, then compare.
• Skipping review and compliance. Segment-specific messages multiply the content that needs approval, and teams that skip review risk making claims that don’t suit a segment. Build medical, legal and regulatory review into the schedule, keep records of approvals and honor opt-outs everywhere. Rushing a campaign past those steps can harm your reputation with the clinicians you hoped to reach, in addition to any legal exposure. Plan the review calendar before drafting begins.

FAQs

What’s an oncologist email list?

 It’s a database of oncology clinicians and their business email addresses, usually filtered by discipline, location and practice. Quality varies by source, verification and tagging. The Shih study identified 28,681 US oncologists in 2019 from NPI data, which holds no email addresses, so vendors add them from other sources. Ask any seller how contacts were collected, when each was verified and what happens when addresses bounce. Request a sample file before paying.

Which oncology subspecialties should I segment by? 

Start with discipline: medical and hematology-oncology, radiation, surgical and gynecologic, and pediatric hematology-oncology. The study reports more than 55% in the first group, 20.6% radiation and 10.5% pediatric. Then add disease site, such as breast, lung, gastrointestinal, genitourinary and hematologic cancers, which OneOncology uses for its disease groups. Choose only the splits you can support with data and content. Review the outcome after each campaign and drop splits that don’t change replies.

Will segmentation actually lift response? 

Probably, if the segments are accurate and the messages fit them, but I found no published measurement for oncologist lists. IQVIA reports a 33% open rate for triggered emails versus 25.3% for broadcast, from a vendor post with no sample. Run a controlled split test with randomized groups, judge by replies and compare the gain with the segmentation cost before you scale. Plan the sample size and the success measure before the test begins.

How do I find out which cancers an oncologist treats?

 NPI taxonomy codes show broad specialty rather than tumor focus. You can infer focus from practice websites, trial listings, publications and conference activity, or buy vendor tags. Each source has gaps, and focus changes over time. Treat inferred tags as probabilities, test a sample of contacts you know and ask the vendor to explain its method and refresh schedule. Ask for a written method statement and a refresh schedule from each vendor.

How fast does oncologist contact data go stale? 

No source I found measures it for oncology. IQVIA claims up to 40% of healthcare professionals change segments within 6 months, which is a vendor claim without a stated sample. The Shih study lists structural problems with NPI data, including single locations and no automatic deactivation. Verify addresses and update tags before every campaign, and track the last-verified date for each record. Re-verify oncology records more often if your product launches soon.

Does CAN-SPAM apply to email to physicians? 

A vendor summary of the FTC’s CAN-SPAM guide says there’s no business-to-business exception and lists requirements such as accurate headers, a physical address and an opt-out honored within 10 business days. I couldn’t open the FTC guide itself. Other laws and promotional rules may also apply, so ask counsel and your regulatory reviewers to approve your plan before you send. Keep copies of your counsel’s advice and the review approvals with the campaign file.

How often should I email oncologists?

 H1’s 2018 guide suggests about 2 emails a month, 2 weeks apart, for long campaigns and weekly emails for campaigns of 30 days or less, without primary data. Treat that as a starting point, then watch unsubscribes and complaints by segment. Lower the frequency where they rise, and make sure each message is relevant to the segment and short enough to read on a phone. Compare engagement for each group before changing the schedule.

How big should a segment be before I test it? 

There’s no sourced rule. As an illustration, a 300-contact segment with a 1% response rate yields 3 replies, too few to compare reliably. Combine neighboring segments or repeat tests across campaigns until enough replies exist to judge. Record segment sizes, dates and versions, and repeat any surprising result before you change your program. That keeps results from being driven by a few lucky replies. Aim for enough contacts that you can expect 12 or more replies per version.